InsidersTradesSigma
Follow the 큐리언트 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 큐리언트 has recorded 103 public disclosures. Market capitalisation: €814.2bn. The latest transaction was filed on 3 April 2026 (Purchase). Among the most active insiders: 동구바이오제약. Every trade is openly available.
101
Insider Decl.
n/a
Thresholds
€42,602
32 ops.
Buy Volume
n/a
5 ops.
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,069 of 28,896 companies
17.5
score / 100
Value26
Quality9
FCF yld-3.4%
Earn yld-3.2%
EV/EBITDA·
ROE-75%
Gross mgn13%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 3 April 2026
Declarations103 total
Other
Other
80,000 sharesKRXDART:20260303002340
1,487,693 sharesKRXDART:20241129000711
1,661,065 sharesKRXDART:20241029000023
1,661,065 sharesKRXDART:20241028000395
5,037,281 sharesKRXDART:20240805000130
25 of 103 declarations
About 큐리언트
큐리언트 is a company in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative treatments for various diseases.